Benzinga
Benzinga
Benzinga
mercoledì, settembre 30

Jaguar Health Inc

JAGXNASDAQ
Trade with Public
Trade with Public
$4.64
-0.68-12.78%
Ult. Agg.: Sep 30, 1:10 PM
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaRapporto azionario

Jaguar Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jaguar Health (JAGX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$31500Upside to Avg. PT+678779.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
May 19, 2025First BerlinChristian OrqueraInitiateBuy$60

Analyst Ratings News

PRO
First Berlin Initiates Coverage On Jaguar Health with Buy Rating, Announces Price Target of $60

First Berlin analyst Christian Orquera initiates coverage on Jaguar Health (NASDAQ:JAGX) with a Buy rating and announces Price Target of $60.
Benzinga Newsdesk

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

Ladenburg Thalmann Raises Jaguar Health Price Target To $13

Bill Haddad

Why Jaguar Health Shares Are Trading Higher Today

Jaguar Health (NASDAQ: JAGX) shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a $5 price target.
Bill Haddad

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021

 
Benzinga Insights

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved